Question and answers on the preclinical safety evaluation of biotechnology-derived pharmaceuticals(WORKSHOP 1 : THE WAY TOXICITY EVALUATIONS OF BIO-PHARMACEUTICAL PRODUCTS SHOULD BE CONDUCTED (TOXICOLOGICAL QUESTIONS & ANSWERS-ISSUE 2002).ICH-S6)

スポンサーリンク

概要

• 論文の詳細を見る
• 日本トキシコロジー学会の論文

著者

• Kobayashi Takayoshi

  Amgen Limited

関連論文

• Question and answers on the preclinical safety evaluation of biotechnology-derived pharmaceuticals(WORKSHOP 1 : THE WAY TOXICITY EVALUATIONS OF BIO-PHARMACEUTICAL PRODUCTS SHOULD BE CONDUCTED (TOXICOLOGICAL QUESTIONS & ANSWERS-ISSUE 2002).ICH-S6)

スポンサーリンク